Crown Laboratories Welcomes Adrianne Shapira to Board, Enhancing Future Growth Potential in Skincare

Crown Laboratories Welcomes Adrianne Shapira to Board of Directors

Crown Laboratories, Inc., a leader in the global skincare sector, has made a significant move by announcing that Adrianne Shapira will be joining its Board of Directors as the Audit Committee Chair. With extensive experience in finance, retail, and consumer brands, Ms. Shapira brings over 20 years of industry expertise to the company. This appointment symbolizes Crown's commitment to enhancing its competitive edge and leadership in skincare innovation.

The Experience of Adrianne Shapira

Adrianne Shapira has a proven track record that spans across multiple significant roles in highly reputed companies. Notably, she dedicated over 13 years at Goldman Sachs, where she served as a Managing Director in Equity Research, overseeing the Broadlines Retail universe. Her leadership roles continued as she became the Chief Financial Officer at David Yurman, a luxury jewelry brand known for its global omni-channel reach. Recently, she excelled as Managing Director at Eurazeo Brands, a mid-market private equity firm.

Crown's Vision for the Future

Crown Laboratories is enthusiastic about Ms. Shapira's addition to the board. Jeff Bedard, the Founder and CEO, expressed his excitement, highlighting that her background and focus on growth will bring valuable insights that align perfectly with the company's goals. 'We are thrilled to welcome Ms. Shapira to our Board of Directors,' Bedard stated. 'Her extensive experience spanning finance, retail, and consumer brands—combined with a proven track record of driving growth and innovation—makes her an invaluable asset as we continue to expand our impact in skincare.'

Crown's unwavering mission is to deliver safe, effective skincare solutions that promote health for a lifetime. The company is committed to scientific excellence and innovation, making its strategy of delivering high-quality skincare products vital in today’s competitive market.

Ms. Shapira's Commitment

Upon her appointment, Ms. Shapira expressed her enthusiasm for joining Crown Laboratories' Board of Directors at such a pivotal time for the company. 'Crown's dedication to innovation and high-quality skincare solutions resonates deeply with my passion for building strong consumer brands,' she noted. Her eagerness to collaborate with the leadership team signifies a promising future for Crown and its stakeholders.

About Crown Laboratories, Inc.

Crown Laboratories is a privately held, fully integrated global skincare company committed to developing a wide array of aesthetic, premium, and therapeutic skincare products. The firm aims to enhance the quality of life for consumers through their skincare journeys. Regarded as an innovator in skin science, Crown has consistently strived for therapeutic excellence, establishing itself as a trusted leader within the realms of Dermatology and Aesthetics. The company has earned a spot on the Inc. 5000 Fastest Growing Privately Held Companies List for eleven consecutive years, showcasing its rapid growth and expansion across over 60 countries worldwide.

For more about Crown Laboratories and their innovative skincare solutions, visit Crown Laboratories.